有机物制造和应用的指导方针:肝脏
Hye-Ran Moon1, Seon Ju Mun1, Tae Hun Kim2,3
1Stem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Korea.
为改善临床前药物毒性测试,提出了肝脏器官的新质量标准. 这些指导方针旨在提高有机体作为动物试验的替代品的可靠性和监管接受度.
科学领域:
- 生物医学工程 生物医学工程
- 毒理学 毒理学 毒理学
- 药物开发 药物开发
背景情况:
- 监管框架越来越倾向于用于临床前药物评估和毒性评估的体外试验.
- 需要先进的肝脏模型来准确预测药物的疗效和毒性.
- 肝脏有机体对药物测试有希望,但缺乏标准化的质量评估,阻碍了监管部门的批准.
研究的目的:
- 为肝脏有机体提出全面的质量标准.
- 针对细胞源验证,有机体生成和功能评估.
- 提高体外毒性测试的可复制性和准确性.
主要方法:
- 开发肝脏有机体的质量标准.
- 包括尺寸,细胞组成和基因表达的标准.
- 整合功能性检测以进行可靠的肝毒性测试.
主要成果:
- 拟议的质量标准涵盖了肝脏有机体的发展和评估的关键方面.
- 这些指导方针有助于验证肝脏器官的有效性,以便可靠地预测药物的有效性和毒性.
- 标准化是加速在药物开发中采用有机体的关键.
结论:
- 确立的质量标准对于肝脏有机体的监管接受至关重要.
- 这些标准将提高体外药物毒性测试的准确性和可重复性.
- 通过这些标准验证的肝脏有机体可以作为动物试验的可靠替代品.
更多相关视频
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
08:15A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024
相关概念视频
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Bioactivation and Tissue Toxicity
Upstream Processing
Production of Pharmaceuticals
